| 33.49 -0.54 (-1.59%) | 09-08 10:40 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 40.71 | 1-year : | 47.55 |
| Resists | First : | 34.86 | Second : | 40.71 |
| Pivot price | 34.17  |
|||
| Supports | First : | 32.45 |
Second : | 30.96 |
| MAs | MA(5) : | 34.1 |
MA(20) : | 33.72 |
| MA(100) : | 30.17 |
MA(250) : | 29.63 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 67.7 |
D(3) : | 74.8 |
| RSI | RSI(14): 52.8 |
|||
| 52-week | High : | 34.86 | Low : | 25.72 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ BMED ] has closed above bottom band by 18.7%. Bollinger Bands are 0.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 34.44 - 34.62 | 34.62 - 34.75 |
| Low: | 33.79 - 33.98 | 33.98 - 34.13 |
| Close: | 34.12 - 34.44 | 34.44 - 34.68 |
BMED focuses on total return by investing in the broad health sciences group of industries from R&D to production and distribution of medical supplies in different fields, including dental, optical or pharmaceuticals. It also involves healthcare providers including health facilities and hospitals or those providing related administrative, management or financial support. The fund reaches into non-human health (e.g., survival of plants and animals) such as firms that increase crop yields, taste, nutritional content or improve pet health. BMED will include firms with varying market-cap with bias to small- and mid-caps that may include foreign non-USD-denominated securities. The fund may also hold REITs that own hospitals and IPOs. During temporary defensive periods, the fund may invest up to 100% of assets in liquid, short-term investments and can enter in credit default swaps for risk management. Prior to Oct. 10, 2024, the fund used Blackrock for branding purposes instead of iShares.
Mon, 24 Aug 2026
Thematic Investing: How the AI Economy Is Expanding - BlackRock
Wed, 19 Aug 2026
Healthcare ETFs rally as Moderna nearly doubles on melanoma win - Seeking Alpha
Mon, 08 Jun 2026
3 Longevity ETFs to Buy and Hold (and Hold) - MarketBeat
Fri, 16 Jun 2023
iShares Health Innovation Active ETF Review and Aggregate Rating (BMED) - MarketBeat
Wed, 14 Jun 2023
FMED ETF Price and Chart — NASDAQ:FMED - tradingview.com
Tue, 31 Jan 2023
MEDX ETF Price and Chart — NASDAQ:MEDX - tradingview.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|